Novel serologic biomarkers provide accurate estimates of recent <i>Plasmodium falciparum</i> exposure for individuals and communities
Danica Helb(University of California, San Francisco), Bryan Greenhouse(University of California, San Francisco), Christopher J. Drakeley(London School of Hygiene & Tropical Medicine), Grant Dorsey(University of California System), Kevin K. A. Tetteh(London School of Hygiene & Tropical Medicine), Harriet Mayanja‐Kizza(Makerere University), Peter D. Crompton(National Institutes of Health), Emmanuel Arinaitwe(Infectious Diseases Research Collaboration), Jordan W. Tappero, James G. Beeson(Burnet Institute), Philip J. Rosenthal(University of California, San Francisco), Moses R. Kamya(University of London), Isaac Ssewanyana(Infectious Diseases Research Collaboration), Jeff Skinner(National Institutes of Health), Philip L. Felgner(University of California, Irvine), David L. Smith(Emergency Medicine Foundation), Alan Hubbard(University of California, Berkeley)
Cited by 219
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
|Science|1993|2.3k
Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000–17: a spatial and temporal modelling study
|The Lancet|2019|500
Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria
|Proceedings of the National Academy of Sciences|2002|461
Nomenclature for Synthetic Gene Delivery Systems
|Human Gene Therapy|1997|450